hi all,
my father was diagnosed w stage 4 prostate ca may 2022. Gleason 9, psa 150s, diffusely metastatic (spine, lower/upper extremity, LN), genetic testing negative.
unfortunately his MO was not well versed on triplet therapy; he underwent 6 rounds of taxotere and started on Luperon q3 months. Nadir i believe was about 0.05?
numbers began to climb after about 1 year of Luperon; added Erleada. Now over the last 8 weeks psa doubling and tripling, at .97 currently.
Thoughts on next steps; trial of taxotere/jevtana?
I'm assuming switching ARI will likely not have a huge effect as it's all same/similar mechanism of action for cancer that's castration resistant now...?
Pluvicto (if even possible to get)...provenge?